Concord Medical Services Holdings Limited Price & Performance (CCM)

StockNews.com has begun coverage on Concord Medical Services, assigning it a "sell" rating. The company's stock has faced challenges, with Friday's opening at $4.36 and a year-high of $26.70. Analysts appear cautious, citing financial metrics like a high debt-to-equity ratio of 1.15 and a low quick ratio of 0.46.1

A recent comparison of Concord Medical Services and SBC Medical Group reveals that Concord's stock carries significant volatility, with a beta of -0.49. This indicates it is 149% less volatile than the S&P 500. Poor financial metrics, including a net loss of $41.93 million, further weigh on the company’s outlook.2

Institutional investors hold 60.8% of SBC Medical Group shares compared to 46.5% for Concord Medical Services. SBC also outperforms Concord in five out of eight financial and operational factors analyzed, making it a stronger contender in the healthcare sector despite its smaller revenue base.2